Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects
- PMID: 29156691
- PMCID: PMC5689581
- DOI: 10.18632/oncotarget.20031
Neutrophils in chronic lymphocytic leukemia are permanently activated and have functional defects
Abstract
A growing body of studies highlights involvement of neutrophils in cancer development and progression. Our aim was to assess the phenotypic and functional properties of circulating neutrophils from patients with chronic lymphocytic leukemia (CLL). The percentage of CD54+ and CD64+ neutrophils as well as CD54 expression on these cells were higher in CLL patients than in age-matched healthy controls. Neutrophils from CLL produced more reactive oxygen species (ROS) compared to controls in both resting and activated conditions. Lipopolysaccharide-induced production of IL-1β and TNF-a as well as reduced TLR2 expression in neutrophils from CLL than in neutrophils from controls suggesting their tolerant state. Finally, phenotypic alterations of neutrophils, particularly elevation of CD64 and CD54 markers, correlated with disease activity and treatment, and low percentage of neutrophils. Taken together, the alterations in percentage and functional characteristics of neutrophils reflect the clinical course of CLL. Our data provide first evidence that neutrophils in CLL are permanently primed and have functional defects.
Keywords: chronic lymphocytic leukemia; disease activity; enhanced ROS production; flow cytometry; neutrophils.
Conflict of interest statement
CONFLICTS OF INTEREST The authors declare that they have no conflicts of interest
Figures






Similar articles
-
Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.Haematologica. 2002 May;87(5):490-9. Haematologica. 2002. PMID: 12010662
-
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.Immunol Res. 2015 Dec;63(1-3):216-27. doi: 10.1007/s12026-015-8722-5. Immunol Res. 2015. PMID: 26478573 Free PMC article.
-
Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.Leukemia. 1993 Feb;7(2):226-34. Leukemia. 1993. PMID: 8381194
-
Adhesion molecules in B-chronic lymphoproliferative disorders.Semin Hematol. 1999 Apr;36(2):178-97. Semin Hematol. 1999. PMID: 10319387 Review.
-
Definition of a target for immunotherapy and results of the first Peptide vaccination study in chronic lymphocytic leukemia.Transplant Proc. 2010 Oct;42(8):3293-6. doi: 10.1016/j.transproceed.2010.07.022. Transplant Proc. 2010. PMID: 20970674 Review.
Cited by
-
CLL cell-derived exosomes alter the immune and hematopoietic systems.Leukemia. 2025 Apr 4. doi: 10.1038/s41375-025-02590-x. Online ahead of print. Leukemia. 2025. PMID: 40186065
-
3D bioprinted white adipose model forin vitrostudy of cancer-associated cachexia induced adipose tissue remodeling.Biofabrication. 2022 May 26;14(3):10.1088/1758-5090/ac6c4b. doi: 10.1088/1758-5090/ac6c4b. Biofabrication. 2022. PMID: 35504266 Free PMC article.
-
Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions.Int J Mol Sci. 2020 Mar 6;21(5):1825. doi: 10.3390/ijms21051825. Int J Mol Sci. 2020. PMID: 32155826 Free PMC article. Review.
-
B Cell Chronic Lymphocytic Leukemia Development in Mice with Chronic Lung Exposure to Coccidioides Fungal Arthroconidia.Immunohorizons. 2023 May 1;7(5):333-352. doi: 10.4049/immunohorizons.2300013. Immunohorizons. 2023. PMID: 37195872 Free PMC article.
-
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.Acta Haematol. 2021;144(5):508-518. doi: 10.1159/000514071. Epub 2021 Feb 25. Acta Haematol. 2021. PMID: 33631756 Free PMC article. Review.
References
-
- Oliveira E, Bacelar TS, Ciudad J, Ribeiro MC, Garcia DR, Sedek L, Maia SF, Aranha DB, Machado IC, Ikeda A, Baglioli BF, Lopez-Duarte N, Teixeira LA, et al. Altered neutrophil immunophenotypes in childhood B-cell precursor acute lymphoblastic leukemia. Oncotarget. 2016;7:24664–24676. https://doi.org/10.18632/oncotarget.8369. - DOI - PMC - PubMed
-
- Fernandez C, Santos-Silva MC, López A, Matarraz S, Jara-Acevedo M, Ciudad J, Gutierrez ML, Sánchez ML, Salvador-Osuna C, Berruezo MJ, Díaz-Arias JÁ, Palomo-Hernández AM, Colado E, et al. Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis. Leukemia. 2013;27:2149–2156. - PubMed
-
- Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6:173–182. - PubMed
-
- Kumar V, Sharma A. Neutrophils: Cinderella of innate immune system. Int Immunopharmacol. 2010;10:1325–1334. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources